Tonix Pharmaceuticals Holding TNXP
NASDAQ TNXP
$5.47 -0.31 (-5.36%)
As of: Oct 21, 2026 · 1:06 PM EDT

Tonix Pharmaceuticals Holding (TNXP) Debt Ratio (2010 - 2024)

Updated

Tonix Pharmaceuticals Holding's (TNXP) Debt Ratio stood at 0.05 in Q4 2024, down 20.3% from 0.06 a year earlier and down 45.4% from the prior quarter.

Analysis

Tonix Pharmaceuticals Holding (TNXP) Debt Ratio (2010 - 2024) Analysis & Trends

Starting with Q4 2010, Tonix Pharmaceuticals Holding's Debt Ratio history includes 13 quarters.

  • Across earlier years, Debt Ratio came in at 0.06 in FY2023.
  • The Q4 2024 figure is the lowest quarterly Debt Ratio since Q2 2014.
  • Per Business Quant, the preceding three quarters came in at 0.08 (Q3 2024), 0.12 (Q2 2024) and 0.07 (Q1 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Eli Lilly 1,133.08 Bn 1,101.67 Bn 19.71 Bn 0.39
2 Johnson & Johnson 616.40 Bn 534.93 Bn 17.26 Bn 0.24
3 AbbVie 501.19 Bn 474.31 Bn 12.70 Bn 0.52
4 Merck 367.18 Bn 321.56 Bn 12.21 Bn 0.42
5 Novartis Ag 297.99 Bn 261.98 Bn 11.24 Bn 0.08
6 Astrazeneca 261.67 Bn 235.36 Bn 12.86 Bn 0.28
7 Amgen 235.57 Bn 190.97 Bn 7.24 Bn 0.60
8 Gilead Sciences 190.62 Bn 164.82 Bn 6.22 Bn 0.53
9 Pfizer 169.63 Bn 116.28 Bn 10.94 Bn 0.31
10 Tonix Pharmaceuticals Holding 91.08 Mn -668.32 Mn 12.84 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 0.05
Sep 30, 2024 0.08
Jun 30, 2024 0.12
Mar 31, 2024 0.07
Dec 31, 2023 0.06
Jun 30, 2014 0.01
Mar 31, 2014 0.01
Dec 31, 2013 0.03
Sep 30, 2013 0.04
Dec 31, 2011 0.35
Sep 30, 2011 48.78
Jun 30, 2011 13.39
Dec 31, 2010 0.05
API Access

Tonix Pharmaceuticals Holding Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=TNXP&period=max&api_key=YOUR_API_KEY